<DOC>
	<DOCNO>NCT00163059</DOCNO>
	<brief_summary>To determine NMDA antagonist , CP-101,606 , effective depression</brief_summary>
	<brief_title>The Antidepressant Effects Of The NMDA Antagonist , CP-101,606 , In Patients With MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Primary DSMIV diagnosis MDD Subjects evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>